UNSPSC 85713635: Revision of spacer in left metacarpocarpal joint, percutaneous approach

This classification denotes the group of activities that yields a surgical intervention or procedure to revision of spacer in left metacarpocarpal joint, percutaneous approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RWT38Z

UNSPSC 85713635 Revision of spacer in left metacarpocarpal joint, percutaneous approach (Commodity) shows minimal alignment with recent state and local procurement activity. The code nominally describes a specific orthopedic surgical procedure, but the recent opportunities tagged under this code reflect a much broader health services market: independent medical evaluation services, pharmacy benefit management, occupational medical surveillance, temporary health professional staffing, surgical center-of-excellence networks, and emergency medical services for youth in custody. None of these procurements involve revision of metacarpocarpal joint spacers or procedure-specific surgical services; the code classification appears to be a data-entry or taxonomy-mapping error rather than a reflection of actual commodity demand.

The issuing bodies include a state department (Washington State Department of Transportation), county governments (Harris County, Collier County, Santa Clara County), and municipal retirement offices (City of Phoenix), but the work being solicited—benefits administration, staffing pools, medical record management, and facility-based care delivery—bears no functional relationship to orthopedic implant procedures. Recent opportunities include Washington State Ferries occupational surveillance (RFP, proposals due October 9, 2026), City of Phoenix disability medical evaluation services (RFP, due October 16, 2026), City of Long Beach surgical center-of-excellence carve-out (RFP, due October 7, 2026), and Collier County pharmacy benefit management (RFP, April 9, 2026 deadline, approximately $8.7 million annual historical spend). This code does not reflect meaningful procurement activity in orthopedic implants, joint spacers, or surgical implant supply—the categories that would logically align with its stated name.